Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AHB-171 in Chronic Hepatitis B
NCT07630727Phase 2Recruiting
- Sponsor
- AusperBio
- Start
- Jun 2026
- Primary completion
- Mar 2029
- Countries
- 1
01
Overview
A Phase 2 trial of AHB-171 in Chronic Hepatitis B (CHB), sponsored by AusperBio. Started Jun 2026; status: recruiting.
02
Drugs
AHB-171
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT07630727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07630727.